» Articles » PMID: 36238270

Dimethyl Sulfoxide-free Cryopreservation Solution Containing Trehalose, Dextran 40, and Propylene Glycol for Therapy with Human Adipose Tissue-derived Mesenchymal Stromal Cells

Overview
Journal Cytotechnology
Specialties Biotechnology
Genetics
Date 2022 Oct 14
PMID 36238270
Authors
Affiliations
Soon will be listed here.
Abstract

We evaluated a dimethyl sulfoxide (Me2SO)-free cryopreservation solution to freeze human adipose-derived mesenchymal stromal cells (hADSCs). In the first experiment, we compared the combined effects of 3% trehalose (3 T) and 5% dextran (5D) in lactated Ringer's solution (LR) as a cryopreservation base solution containing 10% propylene glycol (PG). The cell viability of hADSCs immediately after thawing was significantly higher (p < 0.05) in LR supplemented with 3 T (LR-3 T) and with 3 T and 5D (LR-3 T-5D) than in LR. In the second experiment, we compared the cell characteristics of hADSCs freeze-thawed in LR-3 T-5D containing either 10% Me2SO or 10% PG. The cell viability, annexin V-positive ratio, colony-forming capacity, cell proliferation, cell surface antigen positivity, adipogenic differentiation, osteogenic differentiation, and genetic response to cytokine stimulation of hADSCs immediately after thawing were similar between the LR-3 T-5D containing 10% Me2SO and 10% PG. In the third experiment, we examined various concentrations of PG on the cell proliferative capacity of freeze-thawed hADSCs. The cell proliferative capacity of hADSCs frozen with LR-3 T-5D containing 2.5% to 5% PG was significantly higher (p < 0.05) than LR-3 T-5D containing 10% PG. Furthermore, the cell proliferative capacity of hADSCs frozen with LR-3 T-5D containing 4% PG was similar to that of fresh hADSCs. These results indicate that the combination of 3 T-5D in an LR solution as a basic solution is effective for post-thaw cell viability, and that the optimal concentration of PG to maintain the cell characteristics of hADSCs frozen with LR-3 T-5D is 2.5% to 5%, which is promising for cell therapy applications.

Citing Articles

Factors Defining Human Adipose Stem/Stromal Cell Immunomodulation in Vitro.

Mahmoud M, Abdel-Rasheed M, Galal E, R El-Awady R Stem Cell Rev Rep. 2023; 20(1):175-205.

PMID: 37962697 PMC: 10799834. DOI: 10.1007/s12015-023-10654-7.


Cryopreservation: A Review Article.

Jaiswal A, Vagga A Cureus. 2022; 14(11):e31564.

PMID: 36540535 PMC: 9756256. DOI: 10.7759/cureus.31564.

References
1.
Windrum P, Morris T, Drake M, Niederwieser D, Ruutu T . Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres. Bone Marrow Transplant. 2005; 36(7):601-3. DOI: 10.1038/sj.bmt.1705100. View

2.
Iwatani M, Ikegami K, Kremenska Y, Hattori N, Tanaka S, Yagi S . Dimethyl sulfoxide has an impact on epigenetic profile in mouse embryoid body. Stem Cells. 2006; 24(11):2549-56. DOI: 10.1634/stemcells.2005-0427. View

3.
Shu Z, Heimfeld S, Gao D . Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion. Bone Marrow Transplant. 2013; 49(4):469-76. PMC: 4420483. DOI: 10.1038/bmt.2013.152. View

4.
Awan M, Buriak I, Fleck R, Fuller B, Goltsev A, Kerby J . Dimethyl sulfoxide: a central player since the dawn of cryobiology, is efficacy balanced by toxicity?. Regen Med. 2020; 15(3):1463-1491. DOI: 10.2217/rme-2019-0145. View

5.
Chinnadurai R, Rajan D, Qayed M, Arafat D, Garcia M, Liu Y . Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach. Cell Rep. 2018; 22(9):2504-2517. PMC: 5855117. DOI: 10.1016/j.celrep.2018.02.013. View